Eterna Therapeutics
ERNA
#9563
Rank
S$36.81 M
Marketcap
$0.72
Share price
-16.06%
Change (1 day)
-46.96%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of November 2024 : -3.21

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 168.775.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.19-168.14%๐Ÿ‡บ๐Ÿ‡ธ USA
8.31-359.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.60 12.11%๐Ÿ‡บ๐Ÿ‡ธ USA
1.54-148.11%๐Ÿ‡ซ๐Ÿ‡ท France
5.28-264.61%๐Ÿ‡บ๐Ÿ‡ธ USA
3.03-194.39%๐Ÿ‡ฆ๐Ÿ‡บ Australia
3.03-194.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel